
Opinion|Videos|October 14, 2024
Challenges Associated With Dravet Syndrome Treatment
Author(s)M. Scott Perry, MD
Key Takeaways
- Dravet syndrome's genetic basis and seizure variability complicate treatment, necessitating personalized approaches and regular monitoring.
- Escalation therapy requires careful evaluation of drug efficacy, side effects, and patient-specific factors to ensure optimal outcomes.
Scott Perry, MD, discusses how treatment challenges in Dravet syndrome necessitate careful monitoring by health care providers, who must consider factors such as individual patient response, adverse effect profiles, drug interactions, and the potential need for escalation therapy, to optimize seizure control and overall patient outcomes.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are some treatment challenges associated with Dravet syndrome? (
Strzelczyk, 2022 )- Please describe the different considerations HCPs must take into account when monitoring Dravet syndrome treatment to ensure optimal utilization of escalation therapy options.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
New Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis Treatment
2
Early-Stage Study to Test CD19 CAR T-Cell Therapy YTB323 in Myasthenia Gravis
3
Jessica Neil, PA, on the Evolution of Patients With Headache
4
FDA Approves Doxecitine and Doxribtimine Combination Therapy as First Treatment for Thymidine Kinase 2 Deficiency
5





































